Global

Home

About Dynegene

Dynegene Technologies, established in Shanghai, China in 2018, is an innovative high-tech company in the quickly developing field of synthetic biology, and the only enterprise that can commercialize ultra-high-throughput next-generation DNA synthesis in China.

Dynegene has received hundreds of millions of yuan in a Series A+ round of financing, and its external shareholders are well-known investors with strong strategic resources and a wealth of capital.

More

  • 10000㎡

    manufacturing site area

  • 100

    partners

  • 9years

    of cumulative technological platform innovation

Latest Information

282022. 12
News

NEW ! Custom Taqman probe service is now available!

Taqman probe method for qPCR has strong specificity and high sensitivity compared with dye method, and has been widely used in molecular diagnosis, microarray sequencing, human genome engineering, tumor research, forensic identification and other various fields. With professional technicians, advanced DNA synthesizers and mature synthesis and purification methods, Dynegene has launched custom TaqMan probe service, providing various types of fluorescent modifications according to customer need
222022. 12
News

New! | Dark Probe technology improves HRD research – a new tool for precision medicine

Genomic stability can be maintained through Homologous Recombination Repair (HRR) when DNA double-strand breaks occur in normal cells, but mutations in HRR-related genes can cause Homologous Recombination Deficiency (HRD), which manifests as Genomic Scar (GS).
272022. 10
News

Dynegene Technologies, with international advanced DNA high-throughput technology, appeared at the 72nd American Annual Conference of Human Genetics ASHG

On October 25-29 local time, the 72nd American Society of Human Genetics (ASHG) was held in Los Angeles, USA. The American Annual Conference of Human Genetics is the world's largest conference and expo on human genetics.
072022. 09
News

Dynegene upgraded iQuars50 workstation opens a new chapter in the integration of NGS library preparation and capture

In the era of precision medicine, NGS technology continues to break through and develop rapidly, enabling us to have a deeper understanding of the relationship between diseases and genes. However, to achieve precision medicine is not an easy thing, the experimental process is cumbersome, the sequencing results are highly dependent on the operation of technicians, the instability of data and other factors often make the obtained results ultimately unable to meet customer needs. Therefore, it is n
022022. 09
News

Exhibition review, the 7th ENMORE Bio-industry Exhibition in 2022

The 7th EMNORE Bio-industry Exhibition in 2022 has successfully closed. This conference focused on molecular diagnosis, antibody drugs, cell and gene therapy, mRNA and other hot tracks, brought together more than 200 guests including scientists, scholars, entrepreneurs and investors in the first-line fields of government, academia, industry and investment, and jointly discussed the hot topics and development trends of the industry.
202022. 07
News

Dynegene Technologies congratulates ZAODX World Conference on Early Screening of Cancer with the successful closing

From July 15 to 17, 2022, the ZAODX World Conference on Early Cancer Screening was successfully held in Guangzhou. Focusing on the R & D, transformation and application of global cutting-edge technologies for early screening of cancer, this conference built a top global exchange platform from three perspectives: "world pattern", "China exploration" and "solutions". As an innovative high-tech company of synthetic biology in a rapidly developing period and an ente
192022. 07
News

Strategic cooperation, Dynegene Technologies joins hands with ThunderBio to open up a new journey of synthetic life and decoding health!

On July 16, Dynegene Technologies and ThunderBio Innovation officially reached a strategic cooperation. The two sides will give full play to their respective advantages in the field of high-throughput DNA synthesis technology and high-throughput droplet screening technology, jointly explore the new application of innovative microfluidic technology in the field of synthetic biology, and provide high-quality whole-process services and solutions for users and partners in synthetic biology.
062022. 07
News

New products launched ! How to do with library preparation and capture? Don't worry, the upgraded reagents for library preparation and capture bring the good news.

In recent years, with the rapid development of high-throughput sequencing technology, the sequencing cost has gradually decreased. However, at this stage, the cost of whole genome sequencing is still very high, and the extremely large amount of data obtained after sequencing also leads to slow data analysis. Compared with whole genome sequencing, targeted capture sequencing can be enriched for regions of interest, and the amount of sequencing data required for a single sample is significantly re
142021. 10
News

Good news, the R&D and production center of Dynegene Technologies for new generation of DNA synthesis settled in Caohejing Park, Minhang

Autumn rain moist all things, autumn brings prosperous harvest! With the continuous expansion of business and the addition of new partners, the original office space of Shanghai Dynegene Technologies Co., Ltd. has been unable to meet the needs of business. In order to better provide customers with products and services, truly help customers, and continue to empower customers, Shanghai Dynegene Technologies Co., Ltd. decided to relocate from Zhangjiang Cloudcube, Qingpu District, Shanghai, The ne
152021. 07
News

Zhang Mancang, CTO of Dynegene Technologies, received an exclusive interview from Translational Medicine Network: Synthetic biology is an innovative industry. In the future, we still need to make breakthroughs in core technology

Established in 2018, Dynegene Technologies is an innovative high-tech company dedicated to the R & D and application of synthetic biology. The founding team is composed of top scientists and senior industry personnel in the fields related to synthetic biology and genomics, which is committed to breaking through the original "neck clamping" technology in the fields of high-throughput nucleic acid synthesis. Recently, Mr. Zhang Mankang, CTO of Dynegene Technologies, was interviewed
052021. 06
News

Dynegene Technologies has obtained nearly 100 million yuan of A-round investment, which will be used on the new generation of DNA synthesis technology to break through the monopoly of imported products

Recently, Shanghai Dynegene Technologies Co., Ltd. (referred to as"Dynegene Technologies"), a synthetic biology company, announced that it had obtained nearly 100 million yuan in Round A investment. This round of investment was jointly made by Heyu Capital and Chaosheng Capital. The original shareholder Volcanic Capital continues to follow up with the investment. The funds will be used to further consolidate the company 's new generation of ultra-high-throughput DNA synthesis tech
252021. 02
News

The research team of Shanghai Jiaotong University used full exon sequencing to deeply analyze the performance comparison of four capture probes

Next Generation Sequencing (NGS) has become one of the most important tools for genomic research today due to its advantages of high throughput, sensitivity and specificity. Compared with whole genome sequencing, targeted sequencing, such as whole exome sequencing, has the advantages of low cost, high sequencing depth and coverage, and easy data management, and has become a routine technology in basic research and clinical diagnosis. Currently, the types of probes used by existing capture sequen

Join Us

Dynegene is a young and dynamic company. We adhere to the values of "innovation, concentration, trust and inclusion" and firmly believe that talents are the basis of enterprises. We provide a broad development space for you who love innovation and are willing to devote themselves to life sciences. Welcome to Dynegene, release your potential and create the future together!

More

Join Us

Dynegene is a young and dynamic company. We adhere to the values of "innovation, concentration, trust and inclusion" and firmly believe that talents are the basis of enterprises. We provide a broad development space for you who love innovation and are willing to devote themselves to life sciences. Welcome to Dynegene, release your potential and create the future together!

More

Dynegene Next-Gen Synthesis: Powering Biotech Revolution With Nucleic Acids

Contact Us

Tel: 400-017-9077

Address: Floor 2, Building 5, No. 248 Guanghua Road, Minhang District, Shanghai

Email: zhengyuqing@dynegene.com

Follow Us

Copyright © 2024 Shanghai Dynegene Technologies Co., Ltd. All rights reserved.   

Website Map I Privacy Policy